Results 141 to 150 of about 1,389,299 (344)
Molecular Oncology, EarlyView.This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Prehistoric and historic traces in the mtDNA of Mozambique: insights into the Bantu expansions and the slave trade [PDF]
, 2001 Luı́sa Pereira +5 more
openalex +1 more source
Molecular Oncology, EarlyView.This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Historic preservation meets community development [PDF]
For years, community development and historic preservation operated in their own worlds. Today a new awareness of common interests is enabling collaborations that produce benefits for all.Community development ; Historic ...
Kennedy Lawson Smith
core
, 2007 An event to allow students to trace back their ancestry with the assistance of the New England Historic Genealogical ...
Boston University Howard Thurman Center for Common Ground
core
Molecular Oncology, EarlyView.Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Asset Building for Social Change: Pathways to Large-Scale Impact [PDF]
, 2004 Provides an in-depth examination of current and historic initiatives, in an effort to discern patterns of successful scaling up from among Ford's Assets Program portfolios ...
core
Aggressive prostate cancer is associated with pericyte dysfunction
Molecular Oncology, EarlyView.Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source